Skip to main content
. 2022 Dec 17;14(24):6228. doi: 10.3390/cancers14246228
D-2HG D-2-hydroxyglutarate
HT hyperthermia
DSB double-strand break
MUT mutation
IDH1 isocitrate dehydrogenase 1
αKG α-ketoglutarate
NAC N-acetyl cysteine
OCR oxygen consumption rate
OXPHOS oxidative phosphorylation
PARPi poly-(adenosine 5′-diphosphate–ribose) polymerase inhibitor
ROS reactive oxygen species
RT radiotherapy
SSB single-strand break
WT wild type